Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
TATA INDIA PHARMA & HEALTHCARE FUND vs Motilal Oswal BSE Healthcare ETF
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
31 companies both funds hold · largest common part first
Only in A
11 companies · largest first
- Bayer Cropscience Limited2.96%
- PI Industries Limited2.60%
- Sumitomo Chemical India Limited1.38%
- Gillette India Limited1.23%
- Navin Fluorine International Limited1.18%
- Prasol Chemicals Limited0.88%
- Symbiotec Pharmalab Limited0.88%
- Manipal Health Enterprises Limited0.60%
- Zim Laboratories Limited0.58%
- Molbio Diagnostics Limited0.54%
- Gujarat Fluorochemicals Limited0.53%
Only in B
106 companies · largest first
- Laurus Labs Limited4.84%
- Aurobindo Pharma Limited2.90%
- Glenmark Pharmaceuticals Limited2.19%
- Zydus Lifesciences Limited1.82%
- Gland Pharma Limited1.44%
- Krishna Institute of Medical Sciences Limited1.24%
- Neuland Laboratories Limited1.16%
- Wockhardt Limited1.10%
- Piramal Pharma Limited0.81%
- Narayana Hrudayalaya Ltd.0.78%
- Shilpa Medicare Limited0.77%
- Granules India Limited0.76%
- Global Health Limited0.76%
- Onesource Specialty Pharma Limited0.75%
- Rubicon Research Limited0.67%
And 91 more.
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 83.1% | 94.1% | -10.99 pp |
| Chemicals | 5.7% | 0.0% | +5.69 pp |
| Fast Moving Consumer Goods | 1.2% | 0.0% | +1.23 pp |
| Not classified | 9.9% | 5.9% | +4.07 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →